Mark Ragosa insider trades: Kiniksa Pharmaceuticals International (KNSA) stock sales
Trades on the price chart
Daily close, with an arrow on each day they bought or sold
Companies
Where Mark reports to the SEC
Open-market buys and sales
14 trades reported on SEC Form 4, newest first
| Date | Stock | Type | Shares | Price | Value | Holding | Reported |
|---|---|---|---|---|---|---|---|
| Nov 2, 2026 | KNSA | ↓ Sell | 36,783 | $92.16 | $3.4M | Direct | Nov 3, 2026 (1d) |
| Dec 8, 2025 | KNSA | ↓ Sell | 42,841 | $41.49 | $1.8M | Direct | Dec 10, 2025 (2d) |
| Nov 12, 2025 | KNSA | ↓ Sell | 19,900 | $40.94 | $815K | Direct | Nov 14, 2025 (2d) |
| Oct 28, 2025 | KNSA | ↓ Sell | 100 | $41.00 | $4K | Direct | Oct 30, 2025 (2d) |
| Aug 4, 2025 | KNSA | ↓ Sell | 18,889 | $32.89 | $621K | Direct | Aug 6, 2025 (2d) |
| Jun 3, 2025 | KNSA | ↓ Sell | 18,299 | $28.80 | $527K | Direct | Jun 5, 2025 (2d) |
| May 1, 2025 | KNSA | ↓ Sell | 88,395 | $26.56 | $2.3M | Direct | May 1, 2025 (0d) |
| Mar 20, 2025 | KNSA | ↓ Sell | 15,944 | $23.11 | $368K | Direct | Mar 24, 2025 (4d) |
| Mar 19, 2025 | KNSA | ↓ Sell | 20,343 | $23.10 | $470K | Direct | Mar 19, 2025 (0d) |
| Mar 12, 2025 | KNSA | ↓ Sell | 36,372 | $22.25 | $809K | Direct | Mar 14, 2025 (2d) |
| Dec 9, 2024 | KNSA | ↓ Sell | 27,829 | $21.34 | $594K | Direct | Dec 10, 2024 (1d) |
| Dec 5, 2024 | KNSA | ↓ Sell | 15,116 | $21.37 | $323K | Direct | Dec 5, 2024 (0d) |
| Jul 23, 2024 | KNSA | ↓ Sell | 24,248 | $24.79 | $601K | Direct | Jul 25, 2024 (2d) |
| Jan 3, 2024 | KNSA | ↓ Sell | 12,000 | $20.00 | $240K | Direct | Jan 4, 2024 (1d) |
Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.
Other KNSA insiders
Open-market trades in the last 12 months
About Mark Ragosa's insider trades
Mark Ragosa is Chief Financial Officer at Kiniksa Pharmaceuticals International (KNSA). Since Jan 3, 2024, Mark has reported no open-market purchases and 14 sales worth $12.9M on SEC Form 4. In the last 12 months: 3 sales ($6.0M).
Their filings also include option exercises (34 filings), shares withheld for taxes (21 filings), grants and awards (15 filings). These aren't open-market trades and aren't counted above.
How to read insider trades
Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every KNSA insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.